Gabapentin and Pregabalin Use in First Trimester of Pregnancy and Risk of Specific Congenital Anomalies: An IMI ConcePTION European Case-Malformed Control Study.
Saved in:
| Title: | Gabapentin and Pregabalin Use in First Trimester of Pregnancy and Risk of Specific Congenital Anomalies: An IMI ConcePTION European Case-Malformed Control Study. |
|---|---|
| Authors: | Beau AB; CERPOP, Inserm U1295, Université de Toulouse Paul Sabatier, Service de Pharmacologie Clinique, CHU de Toulouse, 37 allées Jules Guesde Bat C, floor 3, 31000, Toulouse, France. anna-belle.beau@univ-tlse3.fr., Castro EC; CERPOP, Inserm U1295, Université de Toulouse Paul Sabatier, Service de Pharmacologie Clinique, CHU de Toulouse, 37 allées Jules Guesde Bat C, floor 3, 31000, Toulouse, France., Benevent J; CERPOP, Inserm U1295, Université de Toulouse Paul Sabatier, Service de Pharmacologie Clinique, CHU de Toulouse, 37 allées Jules Guesde Bat C, floor 3, 31000, Toulouse, France., Beslay M; CERPOP, Inserm U1295, Université de Toulouse Paul Sabatier, Service de Pharmacologie Clinique, CHU de Toulouse, 37 allées Jules Guesde Bat C, floor 3, 31000, Toulouse, France., Barrachina-Bonet L; Rare Diseases Research Unit, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region, Valencia, Spain., Bergman JEH; Department of Genetics, EUROCAT Northern Netherlands, University of Groningen, University Medical Center Groningen, Groningen, Netherlands., Cavero-Carbonell C; Rare Diseases Research Unit, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region, Valencia, Spain., Coi A; Unit of Epidemiology of Rare Diseases and Congenital Anomalies. Institute of Clinical Physiology, National Research Council, Pisa, Italy., Dolk H; School of Medicine, Ulster University, Belfast, United Kingdom., Garne E; Department of Paediatrics and Adolescent Medicine, Lillebaelt Hospital, University Hospital of Southern Denmark, Kolding, Denmark., Gatt M; Malta Congenital Anomalies Registry, Directorate for Health Information and Research, Pietà, Malta., Hoareau J; Unit of congenital malformations, REMACOR- Medical School University of La Réunion St Pierre, Sainte-Clotilde, France., Hond ED; Provincial Institute of Hygiene, Antwerp, Belgium., Latos-Bielenska A; Department of Medical Genetics, Poznan University of Medical Sciences, Poznań, Poland., Lelong N; Paris Registry of Congenital Malformations, Obstetrical, Perinatal and Paediatric Epidemiology Research Team, INSERM, UMR 1153, Paris, France., O'Mahony M; Department of Public Health, Health Service Executive-South, Cork, Ireland., Moisset X; Université Clermont Auvergne, CHU de Clermont-Ferrand, Inserm, Neuro-Dol, Clermont-Ferrand, France., Morris J; Population Health Research Institute, St George's, University of London, London, United Kingdom., Neville AJ; IMER Registry (Emilia Romagna Registry of Birth Defects, Centre for Clinical and Epidemiological Research, University of Ferrara, Azienda, Ospedaliero Universitaria di Ferrara, Ferrara, Italy., Sichitiu J; Department of Woman-Mother-Child, University Hospital Center CHUV, 1011, Lausanne, Switzerland., Loane M; Institute of Nursing and Health Research, Ulster University, Belfast, United Kingdom., Damase-Michel C; CERPOP, Inserm U1295, Université de Toulouse Paul Sabatier, Service de Pharmacologie Clinique, CHU de Toulouse, 37 allées Jules Guesde Bat C, floor 3, 31000, Toulouse, France. |
| Source: | Drug safety [Drug Saf] 2026 Jun 02. Date of Electronic Publication: 2026 Jun 02. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9002928 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1942 (Electronic) Linking ISSN: 01145916 NLM ISO Abbreviation: Drug Saf Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
